Dr. Reddy's Laboratories
RDY
#1699
Rank
A$17.86 B
Marketcap
A$21.36
Share price
0.35%
Change (1 day)
-4.18%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Total debt

Total debt on the balance sheet as of September 2025 : A$0.99 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's total debt is A$0.99 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Dr. Reddy's Laboratories - Total debt on balance sheet (from 2001 to 2025)

Total debt by year

Year Total debt Change
2025-03-31A$0.87 B138.47%
2024-03-31A$0.36 B50.13%
2023-03-31A$0.24 B-58.86%
2022-03-31A$0.59 B9.16%
2021-03-31A$0.54 B14.03%
2020-03-31A$0.47 B-38.47%
2019-03-31A$0.77 B-23.35%
2018-03-31A$1.01 B2.23%
2017-03-31A$0.99 B50.37%
2016-03-31A$0.65 B-27.45%
2015-03-31A$0.90 B12.98%
2014-03-31A$0.80 B23.71%
2013-03-31A$0.65 B6.58%
2012-03-31A$0.61 B18.92%
2011-03-31A$0.51 B42.92%
2010-03-31A$0.35 B-35.61%
2009-03-31A$0.55 B6.36%
2008-03-31A$0.52 B-26.29%
2007-03-31A$0.71 B-27.56%
2006-03-31A$0.98 B1067.22%
2005-03-31A$84.13 M443.98%
2004-03-31A$15.46 M34.42%
2003-03-31A$11.5 M96.36%
2002-03-31A$5.85 M-96.65%
2001-03-31A$0.17 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
A$91.60 B 9,134.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$25.70 B 2,491.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
A$35.92 B 3,521.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
A$48.20 B 4,759.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$38.43 B 3,774.71%๐Ÿ‡ซ๐Ÿ‡ท France